Healthywomen: Glucose Metabolism and Quality of Life in Healthy Women

Sponsor
Odense University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01995773
Collaborator
(none)
40
1
18
2.2

Study Details

Study Description

Brief Summary

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. Women with PCOS often have problems with fertility, unwanted hair growth, and irregular menstrual cycle. PCOS is associated with obesity, changes in glucose metabolism and low quality of life.

In the present study, hormonal profile, glucose metabolism, adrenal functon, androgen levels, cortisol metabolism, anflammatory response, ovarian morphology, body composition, pfysical activity and quality of life is studied in 40 healthy women. The results will be compared with results from studies on women with PCOS in order to investigate any differences in these parametres.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Glucose Metabolism, Adrenal Function, Cortisol Metabolism, Body Composition Physical Activity, and Quality of Life in Healthy Women
    Study Start Date :
    Dec 1, 2011
    Actual Primary Completion Date :
    Jan 1, 2013
    Actual Study Completion Date :
    Jun 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Healthy Controls

    Healthy control women

    Outcome Measures

    Primary Outcome Measures

    1. Level of androgens [baseline]

      Level of testosterone and sexual hormone binding globuline in blood samples

    Secondary Outcome Measures

    1. Quality of life [Baseline]

      Quality of life measured by validated questionnaires

    2. Body composition [baseline]

      Body composition measured by full body DXA-scan with estimates on lean body mass and fat mass

    3. Bone density [baseline]

      Bone density measured by DXA scan of hip and wrist

    4. Glucose tolerance [5 hours]

      Glucose tolerance measured by 5 hour oral glucose tolerance test with blood glucose measurements for 5 hours after oral intake of 75 g glucose

    Other Outcome Measures

    1. physical activity [one week]

      Physical activity measured by accelerometre

    2. adrenal activity [1 hour]

      Adrenal recativity measured by 1 hour ACTH-stimulation test

    3. Ovarian morphology [at baseline]

      Ovarian morphology described by vaginal ultrasound with measurements of ovarian volumen and description of phollicles.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • healthy

    • No medications

    • regular menstrual cycle

    • no hair growth problems

    • BMI 18-35 kg/m2

    Exclusion Criteria:
    • medication

    • diabetes mellitus

    • signs of PCOS

    • BMI < 18 or > 35

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Odense University Hospital Odense Denmark 5000

    Sponsors and Collaborators

    • Odense University Hospital

    Investigators

    • Principal Investigator: Hanne Mumm, MD, Odense University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marianne Andersen, DMSci, Odense University Hospital
    ClinicalTrials.gov Identifier:
    NCT01995773
    Other Study ID Numbers:
    • 280278
    • 280278
    First Posted:
    Nov 27, 2013
    Last Update Posted:
    Aug 23, 2018
    Last Verified:
    Nov 1, 2013
    Keywords provided by Marianne Andersen, DMSci, Odense University Hospital

    Study Results

    No Results Posted as of Aug 23, 2018